Observational study on bone and soft tissue sarcoma in the Netherlands
Registration Study on Bone and Soft Tissue Sarcoma - An Observational Cohort Study -
This study is collecting health information and experiences from people in the Netherlands who have bone or soft tissue sarcoma to help improve their treatment and care.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Radboud University Medical Center Academic / other |
| Locations | 2 sites (Arnhem and 1 other locations) |
| Trial ID | NCT05373810 on ClinicalTrials.gov |
What this trial studies
This observational cohort study aims to collect both prospective and retrospective clinical data and patient-reported outcomes from individuals diagnosed with bone or soft tissue sarcoma in the Netherlands. The study will gather comprehensive information on medical history, treatment plans, outcomes, and quality of life from patients at various stages of their diagnosis and treatment. By analyzing this data, the study seeks to enhance understanding and improve treatment care for sarcoma patients. It will also serve as a foundation for future research in prognostic and predictive studies, as well as health care policy evaluations.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals with histologically proven bone or soft tissue sarcoma who are currently being treated or planned for treatment.
Not a fit: Patients with altered mental status that prevents them from understanding and providing informed consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment strategies and better quality of life for patients with bone and soft tissue sarcoma.
How similar studies have performed: Other observational studies in similar contexts have shown success in improving treatment outcomes and understanding of sarcoma, indicating that this approach is both relevant and potentially impactful.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Histologically proven bone or soft tissue sarcoma, excluding Gastrointestinal Stromal Tumours Exclusion Criteria: * Altered mental status that would prohibit the understanding of and giving of informed consent
Where this trial is running
Arnhem and 1 other locations
- Radiotherapiegroep — Arnhem, Netherlands (Recruiting)
- Radboudumc — Nijmegen, Netherlands (Recruiting)
Study contacts
- Study coordinator: Pètra Braam, MD/PhD
- Email: p.braam@radboudumc.nl
- Phone: +31243614515
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.